GemOx or GEMOX is an acronym for one of the chemotherapy regimens used in the treatment of relapsed or primary refractory non-Hodgkin's lymphoma and Hodgkin's lymphoma.
When combined with Rituximab it is called R-GemOx, R-GEMOX or GemOx-R, GEMOX-R.
The [R]-GemOx regimen consists of:
Drug | Dose | Mode | Days |
---|---|---|---|
(R)ituximab | 375 mg/m2 | IV infusion | Day 1 |
(Gem)citabine | 1000 mg/m2 | IV infusion in 500 ml normal saline with the speed of 10 mg/m2/min | Day 2 |
(Ox)aliplatin | 100 mg/m2 | IV infusion over 2hrs | Day 2 |